Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2021	0	3.744.224	252.788		1
2015	0	3.554.500	249.216		1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS	2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	2
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA	1
ATLAS MOLECULAR PHARMA SL	1
GIOTTO BIOTECH	1
GLAXOSMITHKLINE VACCINES	1
ICENI DIAGNOSTICS LIMITED	1
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES	1
LUDWIGMAXIMILIANSUNIVERSITAET MUENCHEN	1
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV	1
QUADRAM INSTITUTE BIOSCIENCE	1
STICHTING RADBOUD UNIVERSITEIT	1
STICHTING VUMC	1
SVEUCILISTE U RIJECI MEDICINSKI FAKULTET	1
THE UNIVERSITY OF MANCHESTER	1
UNIVERSITA DEGLI STUDI DI FIRENZE	1
UNIVERSITA DEGLI STUDI DI MILANO	1
UNIVERSITa DEGLI STUDI DI NAPOLI 'FEDERICO II'	1
UNIVERSITEIT LEIDEN	1

Constancy:

Total number of partners: 21
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 21
Frequent / Rare Partner Ratio: 0

Project overview:

Start date	Project	acronym	role	funding	partners
2021-03-01	A multidisciplinary training network for the bioinspired development of glycomimetics tuning the Siglec-Sialoglycan axis	GLYTUNES	participant	3.744.224	11
2015-11-01	A training network for the rational design of the next generation of well-defined glycoconjugate vaccines	GLYCOVAX	participant	3.554.500	12

GLYCOUNIVERSE GMBH & CO. KOMMANDITGESELLSCHAFT AUF AKTIEN - DE